Nicole E. Basler

Internal Medicine
200 W Arbor Dr
San Diego, CA 92103

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer.

Neoadjuvant rituximab modulates the tumor immune environment in patients with high risk prostate cancer.

Journal: Journal of translational medicine
Published: March 27, 2020
Showing 1-1 of 1

Last Updated: 09/26/2026